Clinical Trials Directory

Trials / Unknown

UnknownNCT01383031

Safety and Efficacy Study of Transumbilical Laparoendoscopic Single Site Cholecystectomy

Randomized Controlled Trial Of Transumbilical Laparoendoscopic Single Site Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
Beijing Friendship Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to scientifically evaluate the safety, efficacy and cosmetic results of transumbilical laparoendoscopic single site cholecystectomy.

Detailed description

As the natural orifice during embryonic, the transumbilical surgery not only can mask the abdominal scar and avoid infection produced by puncturing stomach, vagina or rectum in NOTES,but also can be played by the conventional laparoscopic instruments. TU-LESS (transumbilical laparoendoscopic single site surgery), is considered to be the most feasible NOTES(natural orifice transluminal endoscopic surgery)technology at present. Researches about TU-LESS mostly are case reports and small samples or the control experiments up to now,there are not persuasive randomized controlled trail between TU-LESS and conventional laparoscopic cholecystectomy. So the investigators design this prospective randomized controlled trail to scientifically evaluate the safety, efficacy and cosmetic results of transumbilical laparoendoscopic single site cholecystectomy .

Conditions

Interventions

TypeNameDescription
PROCEDURECLCCLC(4 ports or 3 ports)will be performed in a routine fashion by one full time faculty member with fellowship training in laparoscopy.
PROCEDURETU-LESSCTU-LESSC will be performed in a routine fashion which is same to CLC by one full time faculty member with fellowship training in laparoscopy through the conventional laparoscopic instruments.

Timeline

Start date
2010-10-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2011-06-28
Last updated
2011-07-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01383031. Inclusion in this directory is not an endorsement.